Is it Finally Time to Buy Medical Properties Trust?
Medical Properties Trust (NYSE:MPW) is a REIT that focuses on…
Sell
50
GENI Quote, Financials, Valuation and Earnings
Last price:
$10.15
Seasonality move
:
-1.53%
Day range:
$10.01 - $10.93
52-week range:
$4.91 - $11.16
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.58x
P/B ratio:
4.13x
Volume:
3.8M
Avg. volume:
4M
1-year change:
77.76%
Market cap:
$2.4B
Revenue:
$510.9M
EPS (TTM):
-$0.27
Analysts' Opinion
-
Consensus RatingGenius Sports has received a consensus rating of Buy. The company's average rating is a Buy based on 10 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $12.18, Genius Sports has an estimated upside of 19.99% from its current price of $10.15.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $11.00 representing 100% downside risk from its current price of $10.15.
Fair Value
-
According to the consensus of 11 analysts, Genius Sports has 19.99% upside to fair value with a price target of $12.18 per share.
GENI vs. S&P 500
-
Over the past 5 trading days, Genius Sports has underperformed the S&P 500 by -0.98% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Genius Sports does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Genius Sports has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Genius Sports reported revenues of $175.5M.
Earnings Growth
-
Genius Sports has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Genius Sports reported earnings per share of -$0.12.
Enterprise value:
2.3B
EV / Invested capital:
3.93x
Price / LTM sales:
4.58x
EV / EBIT:
--
EV / Revenue:
4.41x
PEG ratio (5yr expected):
--
EV / Free cash flow:
127.94x
Price / Operating cash flow:
132.92x
Enterprise value / EBITDA:
138.35x
Gross Profit (TTM):
$128.7M
Return On Assets:
-8.4%
Net Income Margin (TTM):
-12.34%
Return On Equity:
-11.24%
Return On Invested Capital:
-11.21%
Operating Margin:
-4.26%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $341M | $413M | $510.9M | $127.2M | $175.5M | |
| Gross Profit | $2.9M | $69M | $128.7M | $10.5M | $47.5M | |
| Operating Income | -$181.2M | -$71.7M | -$56.3M | -$34.1M | -$7.5M | |
| EBITDA | -$87M | $5.6M | $16.3M | -$9.8M | $7.9M | |
| Diluted EPS | -$0.90 | -$0.38 | -$0.27 | -$0.17 | -$0.12 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $61.3M | $324.7M | $236.5M | $244.8M | $288.6M | |
| Total Assets | $391M | $887.1M | $773.3M | $775.7M | $792.3M | |
| Current Liabilities | $85.3M | $152.8M | $171.1M | $182.9M | $201.6M | |
| Total Liabilities | $530.4M | $180.9M | $196.5M | $202.7M | $219.9M | |
| Total Equity | -$139.4M | $706.2M | $576.8M | $573M | $572.4M | |
| Total Debt | $93M | $88K | $14.5M | $7.6M | $19K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$3.5M | $14.9M | $81.9M | $24M | $86.6M | |
| Cash From Investing | -$54.8M | -$47.6M | -$62.7M | -$13.5M | -$16.7M | |
| Cash From Financing | -$21K | -$596K | -$7.6M | -$5K | -$6K | |
| Free Cash Flow | -$51M | -$34.3M | $17.6M | $10.6M | $69.9M | |
GENI
Sector
Market Cap
$2.4B
$412.6M
Price % of 52-Week High
90.97%
70.4%
Dividend Yield
0%
0%
Shareholder Yield
--
3.85%
1-Year Price Total Return
77.76%
-15%
Beta (5-Year)
--
0.943
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$10.48
200-day SMA
Buy
Level
$7.92
Bollinger Bands (100)
Buy
Level
8.28 - 9.88
Chaikin Money Flow
Sell
Level
-72.3M
20-day SMA
Buy
Level
$9.75
Relative Strength Index (RSI14)
Buy
Level
54.39
ADX Line
Buy
Level
26.81
Williams %R
Neutral
Level
-45.2301
50-day SMA
Buy
Level
$9.34
MACD (12, 26)
Buy
Level
0.40
25-day Aroon Oscillator
Buy
Level
80
On Balance Volume
Sell
Level
-67.8M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.605)
Buy
CA Score
(Annual)
Level (0.5252)
Buy
Beneish M-Score
(Annual)
Level (-2.6535)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.3639)
Buy
Piotroski F Score
(Annual)
Level (8)
Sell
Quality Ratio Score
Level (3)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas including Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content and Services division. Geographically, the company derives a majority of its revenue from Europe.
Stock Forecast FAQ
In the current month, GENI has received 10 Buy ratings 1 Hold ratings, and 0 Sell ratings. The GENI average analyst price target in the past 3 months is $12.18.
-
Where Will Genius Sports Stock Be In 1 Year?
According to analysts, the consensus estimate is that Genius Sports share price will rise to $12.18 per share over the next 12 months.
-
What Do Analysts Say About Genius Sports?
Analysts are divided on their view about Genius Sports share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Genius Sports is a Sell and believe this share price will drop from its current level to $11.00.
-
What Is Genius Sports's Price Target?
The price target for Genius Sports over the next 1-year time period is forecast to be $12.18 according to 11 Wall Street analysts, 10 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is GENI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Genius Sports is a Buy. 10 of 11 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of GENI?
You can purchase shares of Genius Sports via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Genius Sports shares.
-
What Is The Genius Sports Share Price Today?
Genius Sports was last trading at $10.15 per share. This represents the most recent stock quote for Genius Sports. Yesterday, Genius Sports closed at $10.15 per share.
-
How To Buy Genius Sports Stock Online?
In order to purchase Genius Sports stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Signet Jewelers Stock Go Up So Much?
Signet Jewelers (NYSE:SIG) is the largest diamond retailer in the…
Why Did HealthEquity Stock Fall So Much?
HealthEquity (NASDAQ:HQY) is a fintech company that acts as an…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
78
AJINY alert for Mar 29
Ajinomoto [AJINY] is up 99.61% over the past day.
Buy
85
SLNO alert for Mar 29
Soleno Therapeutics [SLNO] is up 6.8% over the past day.
Buy
69
AGX alert for Mar 29
Argan [AGX] is up 19.83% over the past day.
